|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
10
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LONGEVITATEA este importanta, ne mentinem: Longevivi
LONGEVITATE
| Dimetilaminoetanol (DMAE) cu efect de longevitate |
 |
| Hochschild R. a infiintat un scaner care stabileste virsta biologica umana |
11
Dimetilaminoetanol (DMAE) cu efect la performanta cognitiva la
persoanele in virsta
12 Dimetilaminoetanol
un precursor de colina, creste nivelul in cerebral
a acetilcolinei
13 Dimetilaminoetanol
si efectul in metabolismul cerebral a sintezei de acetilcolina
14 Dimetilaminoetanol
(DMAE) indicat la disfunctia
cerebrala progresiva
15 Dimetilaminoetanol
(DMAE) in tratamentul boli Alzheimer, studiu randomizat,
dublu-orb,
placebo controlat
Creier sanatos
|
Creier cu Alzheimer
|
 |
 |
16 Cercetarea
cresterii nivelului de colina prin Dimetilaminoetanol (DMAE)
la dementa degenerativa progresiva
17 Dimetilaminoetanol
(DMAE) in tratamentul de dementa senila
18 Studiu Neuropsihologic cerebral la persoane senile in timpul tratamentului
cu Dimetilaminoetanol
(DMAE)
Poate suplimente de anti Alzheimer prelungi viata longevitate anti-imbatranire Anti-Aging
19
Longevitate cu: Dimetilaminoetanol
(DMAE) cu proprietati
antioxidative de reducere a radicalilor liberi, Anti-Ageing care intirzie procesul de imbatranire, ne mentinem: Longevivi
20
Baza teoretica a terapiei
cu Procaina in tratamentul longevitatii
Molecula de Procaina hidrolizeaza in doua fractiuni: Acid paraaminobenzoic
- PABA si dietilaminoetanol (DEAE).
Farmacocinetica absorbtiei la:
PABA
- DMAE - DEAE - GERO VITAL H3
Sa absorbit foarte bine dupa administrare in primele 240 de minute amindoi
metaboliti: PABA
si DMAE
Persoanele in virsta au datorita tesutului o afinitate de absobtie mai mare
| Longevitate cu: DMAE si PABA - Acid-paraaminobenzoic o alternativa la Procaina |
 |
Procaina prin transformari carboxilice se fractioneaza in saruri de
etanolamina - Dimetilaminoetanol (DMAE), Dietilaminoetanol (DEAE)
21 Experiment clinic farmacologic
cu procaina
| Structura chimica similara intre DMAE si DEAE |
 |
22 Procaina HCL (GERO VITAL H3) Longevitate un competitiv inhibitor
de monoaminooxidaza
23 Terapia cu Procaina (GERO VITAL H3): mecanismul
inhibitiei de monoaminooxidaza
24Procaina hidroclorid (GERO VITAL
H3) un inhibitor de monoaminooxidaza: Longevitate implicatia la terapia de Geriatrie
25GERO VITAL H3 cu efect in activitatea
de glucoza 6 fosfat dehidrogenaza
26GERO VITAL H3: Reviu farmacologic
in tratamentul de declin cognitiv
la
virstnici
27Studiul
clinic: GERO VITAL
H3 un antidepresiv
28 Influenta procainei, Acid paraaminobenzoic, Dimetilaminoetanol
(DMAE), Dietilaminoetanol (DEAE) la
longevitate
| Conversia la Dimetilaminoetanol (DMAE) in Colina un precursor de Acetilcolina |
 |
DMAE un precursor de acetilcolina care faciliteaza
memoria, un anti-depressant
Dimetilaminoetanol - DMAE intra in sinteza ciclului de Colina si Acetilcolina
important neurotransmiter
29Stiinta ingrijirii parului: Terapia cu Vitamina B5 (Acid pantotenic)
si Acid paraaminobenzoic care inchide culoarea firului de par
alb.
O deficienta de: Acid paraaminobenzoic (PABA) poate produce stres, dureri
de cap. iritabilitate si par alb.
Acid paraaminobenzoic (PABA) stimuleaza flora intestinala, productia de Vitamina
K, Acid Folic si Tiamina
30 Rolul de DMAE in cosmetica, un produs natural
cosmeceutic
31DMAE
cu efect antirid involvat in citopatologie
32
Longevitate cu: DMAE un produs natural pentru ingrijirea
pielii, reda tonusul si elasticitatea
pierduta
| DMAE un produs natural pentru ingrijirea pielii |
 |
| Cura cu suplimente nutritive produse-naturale din medicina traditionala | |
 |
 |
33 Dimetilaminoetanol in tratamentul
de comportare a copiilor hiperactivi
34 Dimetilaminoetanol(DMAE) cu status psihofiziologic de: ma simt
bine (well beeing), la persoane care sufera de dezechilibru
emotional
Controlul telomere si senescenta imbatranirea celulara
Scurtarea
de telomere este ceasul molecular care declanseaza senescenta (telomere shortening
is the molecular clock that triggers senescence)
Terapia Anti-Aging:
Anti-Aging-Systeme - Formula AntiAging
Anti-Aging-Systeme
- Terapia Anti-Aging
Bibliografie-Referinte: Longevitate
Informatii din bibliografia electronica la tema: Nutritie si sanatate
1
Stenback, F., J. H. Weisburger
and G. M. Williams (1988). "Effect
of lifetime administration of dimethylaminoethanol on longevity, aging
changes, and cryptogenic neoplasms in C3H mice." Mech
Ageing Dev 42(2): 129-38.
Ivy GO, Kanai S, Ohta M, Smith G, Sato Y, Kobayashi
M, Kitani K. Lipofuscin-like substances accumulate rapidly in brain, retina
and internal organs with cysteine
protease inhibition. University of Toronto, Scarborough, Ontario, Canada. Adv
Exp Med Biol. 1989;266:31-45; discussion 45-7.
2 Mann, John. Secrets of Life Extension,
Bantam Books, New York, 1982
4 Terman A, Dalen H, Eaton JW, Neuzil J,
Brunk UT. Aging
of cardiac myocytes in culture: oxidative stress, lipofuscin accumulation, and
mitochondrial turnover. Division of Pathology II, Faculty of Health Sciences,
Linkoping University, SE-58185, Linkoping, Sweden. Ann N Y Acad
Sci. 2004 Jun;1019:70-7.
5
Goyal VK. Lipofuscin
pigment accumulation in human brain during aging. Exp
Gerontol. 1982;17(6):481-7.
Dan Riga, Sorin Riga, Florin Halalau, and Francisc Schneider; Brain
Lipopigment Accumulation in Normal and Pathological Aging; Ann. N.Y. Acad.
Sci. 1067: 158–163
(2006).
6 Katz ML. Potential
reversibility of lipofuscin accumulation. Mason Eye Institute, University
of Missouri School of Medicine, One Hospital Drive, Columbia, MO 65212, USA.
Arch Gerontol Geriatr. 2002 May-Jun;34(3):311-7.
7 Riga S, Riga D. Effects of centrophenoxine
on the lipofuscin pigments in the nervous system of old rats. Brain Res. 1974
Jun 7;72(2):265-75.
8 K. NANDY & G. H. BOURNE Effect
of Centrophenoxine on the Lipofuscin Pigments
in the Neurones of Senile Guinea-pigs Department of Anatomy, Yerkes Regional
Primate Research Center of Emory University. Nature 210, 313 - 314 (16 April
1966); doi:10.1038/210313
9 Riga S, Riga D, Schneider F, Halalau
F. Processing,
lysis, and elimination
of brain lipopigments in rejuvenation therapies. Department of Stress Research & Prophylaxis,
Al. Obregia Clinical Hospital of Psychiatry, Bucharest, Romania. Ann N Y Acad
Sci. 2006 May;1067:383-7.
10 Hochschild R. Effect of dimethylaminoethanol
on the life span of senile male
A/J mice. Exp Gerontol 1973, 8(4): 185-191.
11 Marsh GR, Linnoila M. The
effects of deanol on cognitive performance and electrophysiology in elderly
humans. Psychopharmacology (Berl). 1979;66(1):99-104.
Kostopoulos, G.K. & Phillis, J.W. (1975). “The effects of dimethylaminoethanol
(deanol) on cerebral cortical neurons.” Psychopharmacology Communications;
1(3): 339–47.
12 Haubrich
D.R., Wang P.F., D.E. Clody D.E.,Wedecking P.W. Increase in rat brain acetylcholine
induced by choline
or deanol. Life Sci 1975, 17: 975-980.
13 Jope R.S., Jenden D.J. Dimethylaminoethanol
(deanol) metabolism in rat brain and its effect on acetylcholine synthesis.
J Pharmacol Exp Ther 1979, 211:472-479.
14 Lewis,
J. A. and B. S. Lewis (1977). "Deanol in minimal brain dysfunction." Dis
Nerv Syst 38(12 Pt 2): 21-4.
15 Fisman M,
Mersky H, Helmes E. Double-blind trial of 2-dimethylaminoethanol
in Alzheimer’s disease. Am J Psychiatry 1981;138:970–2.
16 Russell RW, Jenden DJ, Booth RA,
Lauretz
SD, Rice KM, Roch M. Global
in vivo replacement of choline by N-aminodeanol. Testing a hypothesis about progressive
degenerative dementia: II. Physiological and behavioral effects. Department
of Pharmacology, School of Medicine, University of California, Los Angeles 90024.
Pharmacol Biochem Behav. 1990 Dec;37(4):811-20.
17 Ferris,
S. H., G. Sathananthan, S. Gershon and C. Clark (1977). "Senile dementia:
treatment with deanol." J Am Geriatr Soc 25(6): 241-4.
18 Bonavita,
E. (1986). "[Neuropsychological study of the senile brain during and after
single and combined treatment with
deanol and citicoline]." Clin Ter 117(5): 387-98.
19 Nagy I, Floyd RA. Electron
spin resonance spectroscopic demonstration of the hydroxyl free radical scavenger
properties of dimethylaminoethanol in spin trapping experiments confirming the
molecular basis for the biological effects of centrophenoxine. Arch Gerontol
Geriatr. 1984 Dec;3(4):297-310.
20 Aslan, A. Theoretical bases of
procaine therapy (Gerovital H3 and Aslavital) in the prophylaxis of aging.
Romanian Journal of Gerontology and Geriatrics,
1: 1, 5-15, 1980.
21 Stroescu, V. The experimental
and clinical pharmacology of procaine, Gerovital H3 and Aslavital. Romanian
Journal of Gerontology and Geriatrics, No.4, Volume
9, pp. 427-437. 1988.
22 MacFarlane MD. Procaine
HCl (Gerovital H3): a weak, reversible, fully competitive inhibitor of monoamine
oxidase. Fed Proc. 1975 Jan;34(1):108-10.
23 MacFarlane MD, Besbris H.Procaine
(Gerovital H3) therapy: mechanism of inhibition
of monoamine oxidase. J Am Geriatr Soc. 1974 Aug;22(8):365-71.
24 Fuller RW, Roush BW. Procaine
hydrochloride as a monoamine oxidase inhibitor: implications for Geriatric
therapy. J Am Geriatr Soc. 1977 Feb;25(2):90-3.
25 Cruceanu A, Bucsa L. Age
differences in the glucose-6-phosphate dehydrogenase activity of homogenates
from the liver of rats. The effect of gerovital H3 on the glucose-6-phosphate
dehydrogenase activity. Physiologie. 1979 Jan-Mar;16(1):71-5.
26 Reisberg B, Ferris SH, Gershon S. An
overview of pharmacologic treatment of cognitive decline in the aged. Am
J Psychiatry. 1981 May;138(5):593-600.
27 Olsen EJ, Bank L, Jarvik LF. Gerovital-H3:
a clinical trial as an antidepressant.J Gerontol. 1978 Jul;33(4):514-20.
28 Verzar F. Note on the influence
of procaine, PABA and DEAE on the aging of rats. Basel, 1959, Gerontology 3,6,
350-355.
29 Zarafonetis, CJ. Darkening
of gray hair during para-amino-benzoic acid therapy. J Invest Dermatol.
1950
Dec;15(6):399-401.
Zvak, C. The Science of Hair Care, 1986, Marcel Dekker, Inc., New York.
Brandaleone, H., Maine, E., and Steele, J.M. The effect of calcium pantothenate
and para-aminobenzoic acid on gray hair in man. Am J Medical Science, 1944, 206:
315
30 Grossman R. The
role of dimethylaminoethanol in cosmetic dermatology. Johnson and Johnson
Consumer Products Worldwide, Skillman, NJ 08558, USA. Am J Clin Dermatol. 2005;6(1):39-47
31 The
antiwrinkle effect of topical concentrated 2-dimethylaminoethanol involves
a vacuolar cytopathology.
Morissette G, Germain L, Marceau F. Centre de Recherche en Rhumatologie et Immunologie,
Centre Hospitalier Universitaire de Québec, Québec QC, Canada.
Br J Dermatol. 2007 Mar;156(3):433-9.
32 Uhoda I, Faska N, Robert C, Cauwenbergh
G, Piérard GE. Split
face study on the cutaneous tensile effect of 2-dimethylaminoethanol (deanol)
gel. Unit of Dermocosmetology, Department of Dermatopathology, University
Medical Center of Liège, CHU Sart Tilman, B-4000 Liège, Belgium.
Skin Res Technol. 2002 Aug;8(3):164-7.
33 Oettinger, L. The use of Deanol
in the treatment of disorders of behavior in children. J. Pediat, 1958, 53:
761-675.
Coleman, N., Dexheimer, P., Dimascio, A., Redman, W., and Finnerty, R. Deanol
in the treatment of hyperkinetic children. Psychosomatics, 1976, 17: 68-72.
Kugel, R. B., and Alexander, T. The effect of a central nervous system stimulant
(Deanol) on behavior. Pediatrics. 1963, 31: 651-655.
34 Dimpfel W, Wedekind W, Keplinger
I. Efficacy
of dimethylaminoethanol (DMAE) containing vitamin-mineral drug combination
on EEG patterns in the presence
of different emotional states. Pro Science, Private Research Clinic GmbH
- med. Forschung und Entwicklung -, Kurt-Schumacher-Str. 9, D-35440 Linden, Germany.
w.dimpfel@mewicon.at Eur J Med Res. 2003 May 30;8(5):183-91.
Secretul Longevitatii: Mentinerea de Hemoglobina glicozilata - (HbA1c) la valoarea de 5%, valoare
optimala pentru controlul metabolic si a longevitatii este reducerea glucozei
la nivelul de 70 - 80 mg/dl
Ce nu va relateaza medicul despre diabet de la Life Extension
director medical: Dr. Steven V. Joyal
Parerea din pasajele acestui site nu a fost independent cercetate sau confirmate.
